Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.7304 |
| Open | 0.7187 |
| Bid | 0.6980 x 300 |
| Ask | 0.7236 x 300 |
| Day's Range | 0.7000 - 0.7300 |
| 52 Week Range | 0.5000 - 4.6700 |
| Volume | |
| Avg. Volume | 653,209 |
| Market Cap | 38.648M |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report
As you might know, Cara Therapeutics, Inc. ( NASDAQ:CARA ) last week released its latest full-year, and things did not...
- Simply Wall St.
Cara Therapeutics Full Year 2023 Earnings: Misses Expectations
Cara Therapeutics ( NASDAQ:CARA ) Full Year 2023 Results Key Financial Results Revenue: US$21.0m (down 50% from FY...
- Insider Monkey
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
© 2024 Yahoo. All rights reserved.